Comparison of a silicon-carbide coated stent versus a noncoated stent in humans: The Tenax™- versus Nir™-stent study (TENISS)

Journal of Interventional Cardiology

Volumn 16, Issue 4, 2003, Pages 325-333

  Unverdorben, Martin ^a,d   Sattler, Katherine ^a   Degenhardt, Ralf ^a   Fries, Roland ^b   Abt, Bernd ^a   Wagner, Eberhard ^a   Koehler, Henning ^a   Scholz, Manfred ^a   Ibrahim, Hassan ^a   Tews, Karl Heinz ^c   Hennen, Benno ^b   Daemgen, Gabriele ^a   Berthold, Heiner K ^a   Vallbracht, Christian ^a  

^a Center for Cardiovascular Diseases   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c GOETHE UNIVERSITY   (Germany)

^d Center for Cardiovascular Diseases   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; SILICON CARBIDE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTICLE; CAUSE OF DEATH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY THROMBOSIS; CORONARY STENT; CREATINE KINASE BLOOD LEVEL; FEMALE; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBSERVATION; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; TREATMENT OUTCOME;

CARBON COMPOUNDS, INORGANIC; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSTHESIS DESIGN; SILICON COMPOUNDS; STENTS;

EID: 10744221561     PISSN: 08964327     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-6143.2003.08058.x     Document Type: Article

References (50)

1. Marso S, Ellis S, Raymond R. Intracoronary stenting: An overview for the clinician. Cleve Clin J Med 1999;66:434-442.
2. Unverdorben M, Vallbracht C. Stents in the second decade meshes maturate? Prog Biomed Res 1999;4:23-31.
3. Fernandez-Ortiz A, Goicolea J, Perez-Vizcanyno M, et al. Late clinical and angiographic outcome of bailout coronary stenting. A comparison study between Gianturco-Roubin and Palmaz-Schatz stents. J Am Coll Cardiol 1996;27:111A.
4. Hamasaki N, Nosaka H, Kimura T, et al. Serial angiographic follow-up after Cordis-Stent implantation. A comparison with Palmaz Schatz stent. Am J Cardiol 1996;27:138A.
5. Rau T, Tschirner BI, Mathey DG, et al. Comparison of restenosis rates after placement of Palmaz-Schatz stents and A.V.E. micro stents. Eur Heart J 1996;17:179.
6. Eeckhout E, van Melle G, Stauffer J, et al. Can early closure and restenosis after endoluminal stenting be predicted from clinical, procedural, and angiographic variables at the time of intervention? Br Heart J 1995;74:592-597.
7. Dussaillant G, Mintz G, Pichard A, et al. Small stent size and intimal hyperplasia contribute to restenosis: A volumetric intravascular ultrasound analysis. J Am Coll Cardiol 1995;26:720-724.
8. Park SW, Park HK, Hong MK, et al. Comparison of slotted tube versus coil stent implantation for ostial left anterior descending coronary artery stenosis: Initial and late clinical outcomes. J Korean Med Sci 1998;13:483-487.
9. MacIsaac AI, Ellis SG, Muller DW, et al. Comparison of three coronary stents: Clinical and angiographic outcome after elective placement in 134 consecutive patients. Cathet Cardiovasc Diagn 1994;33:199-204.
10. Akiyama T, Moussa I, Reimers B, et al. Angiographic and clinical outcome following coronary stenting of small vessels: A comparison with coronary stenting of large vessels. J Am Coll Cardiol 1998;32:1610-1618.
11. Carrillo-Calvillo J, Martinez-Elbal L, Gomez-Recio M, et al. A comparison of clinical and angiographic outcome after implantation of a Wiktor stent in large and small coronary arteries. Arch Inst Cardiol Mex 1998;68:492-497.
12. Kuntz R, Safian R, Levine M, et al. Novel approach to the analysis of restenosis after the use of three new coronary devices. J Am Coll Cardiol 1992;19:1493-1499.
13. Kuntz R, Gibson C, Nobuyoshi M, et al. Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomy. J Am Coll Cardiol 1993;93:15-25.
14. Dean L, Roubin G, O'Shaugnessy C, et al. Elective stenting of de-novo lesions: Randomized multicentre trial comparing two stent designs. Eur Heart J 1997;80(Suppl. 7A):349.
15. Noeldge G, Richter G, Siegestter V, et al. Tierexperimentelle Untersuchungen über den Einfluβ der Flussrestriktion auf die Thrombogenität des Palmaz-Schatz Stents mittels 111-Indium markierter Thrombocyten. Röfo 1990;152:264-270.
16. Jollis JG, Peterson ED, Nelson CL, et al. Relationship between physician and hospital coronary angioplasty volume and outcome in elderly patients. Circulation 1997;96:2485-2491.
17. Ellis SG, Omoigui N, Bittl JA, et al. Analysis and comparison of operator-specifc outcomes in interventional cardiology. Circulation 1996;93:431-439.
18. Califf RM, Jollois JG, Peterson ED. Operator-specific outcomes. Circulation 1996;93:403-406.
19. Ellis S, Weintraub W, Holmes D, et al. Relation of operator volume and experience to procedural outcome of percutaneous coronary revascularization at hospitals with high interventional volumes. Circulation 1997;96:2479-2484.
20. Özbek C, Heisel A, Groβ B, et al. Coronary implantation of silicon-carbide-coated Palmaz-Schatz stents in patients with high risk of stent thrombosis without oral anticoagulation. Cathet Cardiovasc Diagn 1997;41:71-78.
21. Serruys P, Buller C, Bonnier J, et al. Quantitative angiographic results of the phosphorylcholine coated bio-divY sio stent in the SOPHOS study. Eur Heart J 1999;20:272.
22. Bartorelli A, Fabbiocchi F, Loaldi A, et al. Clinical and angiographic evaluation of the CARBOSTENT: A new cellular design carbofilm coated coronary stent. Am J Cardiol 1999;84 (Suppl.):109P.
23. Schömig A, Kastrati A, Neumann F, et al. Impact of gold plating on the outcome after coronary stent placement: Results of a randomized trial. Circulation 1998;98(Suppl. I-855.
24. Baurschmidt P, Schaldach M. The electrochemical aspects of the thrombogenicity of a material. J Bioeng 1977:261-278.
25. Bolz A, Schaldach M. Amorphous silicon carbide: A semiconducting coating with superior hemocompatibility. Artif Organs 1991;14:151-160.
26. Bolz A, Harder C, Unverdorben M, et al. Development of a new hybrid coronary stent design with optimized biocompatible properties. In: Wise D, Trantolo D, Lewandrowski K, Gresser J, Cattaneo M, Yaszemski M, eds. Biomaterials, Engineering and Devices: Human Applications. Totowa, NJ: Humana Press, 2001, pp. 201-222.
27. Monnik S, van Boven A, Paals H, et al. Silicon-carbide coated coronary stents have low platelet and leucocyte adhesion during platelet activation. J Invest Med 1999;47:304-310.
28. Rzany A, Bayer G, Schaldach M, et al. Fibrin formation on silicon carbide - A molecular level study with scanning force microscopy. Prog Biomed Res 1999;1:84-89.
29. Hirose M. Glow discharge. In: Pankove J, ed. Semiconductors and Semimetals. New York: Academic Press, 1984.
30. Frey H, Kienel G. Dünnschichttechnologie. Düsseldorf, Germany: VDI-Verlag, 1984.
31. Gronenschild E, Janssen J, Tijdens F. CAAS. II: A second generation system for off-line and on-line quantitative coronary angiography. Cathet Cardiovasc Diagn 1994;33:61-75.
32. Whelan DM, van der Giessen WJ, Krabbendam SC, et al. Biocompatibility of phosphorylcholine coated stents in normal porcine coronary arteries. Heart 2000;83:338-345.
33. Bolz A, Schaldach M. Physikalische Mechanismen an der Phasengrenze a-SiC:H-Fibrinogen. Biomed Technik 1992;37:244-253.
34. Clarotti G, Schue F, Sledz J, et al. Modification of the biocompatible and haemocompatible properties of polymer substrates by plasma-deposited fluorocarbon coatings. Biomaterials 1992;13:832-840.
35. Alt E, Schömig A. The inflow coronary stent. In: Serruys P, Kutryk M, eds. Handbook of Coronary Stents. London: Martin Dunitz, 1998, pp. 265-273.
36. Edelman ER, Karnovsky MJ. Contrasting effects of the intermittent and continuous administration of heparin in experimental restenosis. Circulation 1994;89:770-776.
37. Guyton JR, Rosenberg RD, Clowes AW, et al. Inhibition of rat arterial smooth muscle cell proliferation by heparin. In vivo studies with anticoagulant and nonanticoagulant heparin. Circ Res 1980;46:625-634.
38. Clowes AW, Karnowsky MJ. Suppression by heparin of smooth muscle cell proliferation in injured arteries. Nature 1977;265:625-636.
39. New G, Moses J, Roubin G, et al. The effect of 17beta-estradiol coated stents on the endothelial cell repair, intimal hyperplasia and restenosis. Eur Heart J 2001;22 (Suppl.):483.
40. Drachman DE, Edelman ER, Seifert P, et al. Neointimal thickening after stent delivery of paclitaxel: Change in composition and arrest of growth over six months. J Am Coll Cardiol 2000;36:2325-2332.
41. Herdeg C, Oberhoff M, Baumbach A, et al. Local paclitaxel delivery for the prevention of restenosis: Biological effects and efficacy in vivo. J Am Coll Cardiol 2000;35:1969-1976.
42. Antoniucci D, Bartorelli A, Valenti R, et al. Clinical and angiographic outcome after coronary arterial stenting with the carbostent. Am J Cardiol 2000;85:821-825.
43. Vrolix MC, Legrand VM, Reiber JH, et al. Heparin-coated Wiktor stents in human coronary arteries (MENTOR Trial). Am J Cardiol 2000;86:385-389.
44. Kastrati A, Schomig A, Dirschinger J, et al. Increased risk of restenosis after placement of gold-coated stents. Results of a randomized trial comparing gold-coated with uncoated steel stents in patients with coronary artery disease. Circulation 2000;101:2478-2483.
45. Sousa JE, Costa MA, Abizaid A, et al. Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: A quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 2001;103:192-195.
46. Serruys P, Morice M, Sousa J, et al. The RAVEL study: Arandomized study with the sirolimus coated Bx velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions. Eur Heart J (Suppl.) 2001;22:484.
47. Herdeg C, Oberhoff M, Siegel-Axel DI, et al. Paclitaxel: A chemotherapeutic agent for prevention of restenosis? Experimental studies in vitro and in vivo. Z Kardiol 2000;89:390-397.
48. Kastrati A, Dirschinger J, Boekstegers P, et al. Influence of stent design on 1-year outcome after coronary stent placement: A randomized comparison of five stent types in 1,147 unselected patients. Cathet Cardiovasc Interv 2000;50:290-297.
49. Escaned J, Goicolea J, Alfonso F, et al. Propensity and mechanisms of restenosis in different coronary stent designs: Complementary value of the analysis of the luminal gain-loss relationship. J Am Coll Cardiol 1999;34:1490-1497.
50. Escaned J, Cortes J, Alcocer MA, et al. Long-term angiographic results of stenting in chronic total occlusions: Influence of stent design and vessel size. Am Heart J 1999;138:675-688.